Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
From Bufo Toad Venom to Big Pharma
Research on synthetic 5-MeO-DMT has advanced from early observational studies to positive clinical trials. Scientists have moved from natural toad secretions to standardized 5-MeO-DMT pharmaceutical formulations. Major questions remain regarding…
Pharma giant to relocate research hub to Cambridge in £400m move
Pharmaceutical giant GSK has announced plans to close its main research and development hub in Stevenage, Hertfordshire, in favour of a new flagship facility in Cambridge. This strategic move is part of a broader initiative to slash costs by…
BC Partners to Buy Stake in $1.5 Billion Pharma Firm InfoRLife
BC Partners has agreed to acquire a co-control stake in Swiss pharmaceutical company InfoRLife SA, marking the second deal from its newest flagship fund. The private equity firm is buying the stake from InfoRLife Chief Executive Officer Sergio…
Exclusive: China's up-and-coming pharma giants
Chinese pharmaceutical companies are making inroads, particularly in early-stage research and initial clinical trials, but remain about a decade away from challenging industry heavyweights like AstraZeneca on a global stage, the company's chief…
Trump's generic drug tariffs will test his pharma strategy
President Trump's planned tariffs for generic drugs are the clearest test yet of whether the administration can keep its promises to both increase U.S. drug manufacturing and lower prescription costs. Why it matters: Tariffs could give the country…
Alembic Pharma gets U.S. FDA nod for generic chronic constipation drug
Generic drugmaker Alembic Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for Prucalopride Tablets, 1 mg and 2 mg, used to treat chronic idiopathic constipation…
Nuvectis Pharma (NVCT) Expected to Announce Earnings on Tuesday
Nuvectis Pharma (NASDAQ:NVCT - Get Free Report) is expected to release its Q2 2026 results before the market opens on Tuesday, August 4th. Analysts expect the company to post earnings of ($0.25) per share for the quarter. Interested persons can…
Louise Frederika Kooij Sells 105,000 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CAO Louise Frederika Kooij sold 105,000 shares of the stock in a transaction on Monday, July 20th. The shares were sold at an average price of $30.34, for a total value of…
86,650 Shares in Ascendis Pharma A/S $ASND Bought by Eagle Health Investments LP
Eagle Health Investments LP bought a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 86,650 shares of…
Rock Springs Capital Management LP Acquires 24,750 Shares of BridgeBio Pharma, Inc. $BBIO
Rock Springs Capital Management LP boosted its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 23.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange…
Rock Springs Capital Management LP Has $44.37 Million Holdings in Ascendis Pharma A/S $ASND
Rock Springs Capital Management LP lowered its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 4.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 194,000 shares of the…
Maverick Capital Ltd. Has $69.99 Million Stock Holdings in NewAmsterdam Pharma Company N.V. $NAMS
Maverick Capital Ltd. grew its stake in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 15.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The…
GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley
“A vote of confidence in British business,” trumpeted Andy Burnham, seizing the political gift of GSK splashing out £400m on a shiny new research and development centre in Cambridge. For positive vibes, it definitely beats the…
Hong Kong biopharmaceutical firm partners with regional hubs to drive GBA clinical trials
Hong Kong biopharmaceutical company Health Hope Pharma (HHP) signed a memorandum of understanding on Tuesday with two regional clinical bodies to accelerate new drug development and expand clinical research across the Greater Bay Area (GBA). SCROLL…
Andy to introduce new technical pathways for GCSEs in 2028(!)
Please or to access all these features Join the discussion and chat with other Mumsnetters about everyday life, relationships and parenting. noblegiraffe · Today 11:08 Or perhaps not GCSEs but some other sort of qualification which will…
Receive a Daily briefing on Pharma Industry News
Get Started